Related Experiment Video
Updated: Nov 20, 2025

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.8K
COVID-19 and dementia: experience from six European countries
Alistair Burns1, Antonio Lobo2, Marcel Olde Rikkert3
1University of Manchester, Manchester, UK.
International Journal of Geriatric Psychiatry
|January 19, 2021
Summary
The COVID-19 pandemic disproportionately impacted older adults and individuals with dementia, affecting health outcomes and care. This summary highlights varied European responses and lessons learned for dementia care during crises.
Area of Science:
- Gerontology
- Infectious Diseases
- Neurology
Background:
- The COVID-19 pandemic has had profound global effects, with older adults and those with dementia experiencing disproportionately negative health outcomes.
- This includes increased mortality, morbidity, and long-term neurological damage, alongside challenges in healthcare decision-making.
Observation:
- The International Dementia Alliance, comprising specialists from six European countries, summarized their experiences with COVID-19's impact on these populations.
- Experiences from England, France, Germany, the Netherlands, Spain, and Switzerland revealed differential responses from health and social care systems.
Findings:
- Key themes include the atypical presentation of COVID-19 in older adults and individuals with dementia.
- There was a critical need for specialized care in nursing homes and recognition of the detrimental effects of isolation.
- The complexity of health and social service responses to mitigate the pandemic's negative impact was evident.
Implications:
- The pandemic highlighted the vulnerability of older adults and people with dementia to infectious diseases.
- It underscored the importance of tailored care strategies, particularly in residential settings, and addressing social isolation.
- New working models developed during the crisis may offer a positive legacy for future public health emergencies and dementia care.
Related Concept Videos
Dementia
291
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
291
Alzheimer's Disease: Overview
1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Alzheimer's Disease: Treatment
586
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
586
Cognitive Development During Adulthood
517
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
517
Pharmacodynamics in Geriatric Patients: Effects of Age
99
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
99
Parkinson's Disease: Overview
1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K

